Clinical Management of Localized Colon Cancer with Capecitabine

Large randomized trials demonstrated a benefit of adjuvant chemotherapy after resection of the primary colon cancer. It improves overall survival and reduces the risk of death, by 5% in UICC (Union Internationale Contre le Cancer) stage II and approximately 15%–20% in stage III. Fluoropyrimidines ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Quidde, J., Arnold, D., Stein, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498969/
https://www.ncbi.nlm.nih.gov/pubmed/23170068
http://dx.doi.org/10.4137/CMO.S8194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498969/
https://www.ncbi.nlm.nih.gov/pubmed/23170068
http://dx.doi.org/10.4137/CMO.S8194

Ejemplares similares